Your browser doesn't support javascript.
loading
Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia.
Janovska, Pavlina; Poppova, Lucie; Plevova, Karla; Plesingerova, Hana; Behal, Martin; Kaucka, Marketa; Ovesna, Petra; Hlozkova, Michaela; Borsky, Marek; Stehlikova, Olga; Brychtova, Yvona; Doubek, Michael; Machalova, Michaela; Baskar, Sivasubramanian; Kozubik, Alois; Pospisilova, Sarka; Pavlova, Sarka; Bryja, Vitezslav.
Afiliação
  • Janovska P; Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
  • Poppova L; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic. CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Plevova K; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic. CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Plesingerova H; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic. CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Behal M; Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
  • Kaucka M; Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
  • Ovesna P; Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
  • Hlozkova M; CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Borsky M; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.
  • Stehlikova O; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.
  • Brychtova Y; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.
  • Doubek M; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic. CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Machalova M; Department of Paediatric Otorhinolaryngology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.
  • Baskar S; Genetics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.
  • Kozubik A; Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic. Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic.
  • Pospisilova S; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic. CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Pavlova S; Center of Molecular Biology and Gene Therapy, Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic. CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Bryja V; Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic. Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic. bryja@sci.muni.cz.
Clin Cancer Res ; 22(2): 459-69, 2016 Jan 15.
Article em En | MEDLINE | ID: mdl-26240275
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Quimiotaxia / Proteínas Proto-Oncogênicas / Comunicação Autócrina / Proteínas Wnt / Via de Sinalização Wnt Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Quimiotaxia / Proteínas Proto-Oncogênicas / Comunicação Autócrina / Proteínas Wnt / Via de Sinalização Wnt Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article